Skip to main content
. Author manuscript; available in PMC: 2009 Sep 23.
Published in final edited form as: Hypertension. 2007 Nov 19;51(1):141–147. doi: 10.1161/HYPERTENSIONAHA.107.096552

Table 1.

Characteristics of Case and Control Subjects

All Participants
Participants With Serum Available
Characteristic ACEi-Associated Angioedema (n=50) ACEi-Exposed Control Subjects (n=176) P ACEi-Associated Angioedema (n=38) ACEi-Exposed Control Subjects (n=170) P
Black:white, n 20:30 88:88 0.21 13:25 87:83 0.06
Male:female, n 24:26 85:91 0.97 16:22 83:87 0.45
Age, mean±SD, y 58.6±14.4 58.0±11.1 0.78 59.7±14.7 58.0±11.1 0.52
Nonsmoker:smoker:unknown, n 32:16:2 149:27:0 0.005 27:11 144:26 0.047
Nondiabetic:diabetic:unknown, n 40:9:1 112:64:0 0.02 32:6 60:110 0.02
ACEi:off ACEi, n 15:35 158:18 <0.001 8:30 152:18 <0.001